Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- NCMI +24.2% (approves $100 mln repurchase program) ALPN +5.7%, XPEV +3.4%, TME +0.6%, CNM +0.6%
Other news:
- FUSN +101.1% (Fusion Pharmaceuticals to be acquired by AstraZeneca (AZN) for $21.00 per share in cash at closing plus a non-transferrable contingent value right (CVR) of $3.00 per share)
- CRNX +18% (once-daily oral paltusotine achieved the primary and all secondary endpoints in the phase 3 pathfndr-2 study in acromegaly patients)
- SPIR +16.4% (to Enhance AI-Driven Weather Prediction in Collaboration with NVIDIA)
- LGO +3% (establishing JV with Stryten Energy)
- UL +3% (to accelerate growth action plan through separation of ice cream unit and launch of productivity program)
- GTLS +1.9% (receives order for Lancaster Clean Energy Center)
- SNPS +1.4% (Showcases EDA Performance and Next-Gen Capabilities with NVIDIA Accelerated Computing, Generative AI and Omniverse)
- DRQ +1.1% (combining with Innovex in all-stock transaction)
- CDNS +1% (Revolutionary Cadence Reality Digital Twin Platform to Transform Data Center Design for the AI Era)
- IFF +1% (to sell its Pharma Solutions business unit to French leader of plant-based ingredients Roquette for an enterprise value of up to $2.85 billion)
Analyst comments:
- DKL +1.3% (upgraded to Outperform from Mkt Perform at Raymond James)